Group 1 - The core viewpoint of the news is that New Coordinates (sh603040) reached its daily limit with a price of 105.38 yuan, reflecting a 10% increase and a total market capitalization of 14.38 billion yuan [1] - The company reported a revenue growth of 19.45% year-on-year for Q3 2025, with a net profit increase of 29.41% and a non-recurring net profit growth of 33.88%, indicating strong performance [2] - The company has implemented a cash dividend policy, distributing 2.5 yuan per 10 shares, totaling 33.84 million yuan, which represents 35.58% of its net profit, attracting investor interest [2] Group 2 - The governance structure has been optimized by canceling the supervisory board and establishing an audit committee, along with revising 28 internal regulations, enhancing corporate governance [2] - The automotive parts sector has been active recently due to the growth in new energy vehicle production and sales, benefiting companies like New Coordinates, which supplies precision cold-forged components for automotive engine timing mechanisms [2] - Technical indicators such as the MACD may attract technical investors if a bullish crossover occurs, and there may have been significant capital inflow on the day of the stock's limit-up [2]

"一滴原油"的化学反应为何在此生发？ 信德新材料产业园。 记者 王延辉 摄 在因油而建、因油而兴的濮阳，"一滴原油"的旅程正被重新定义。 1月20日，大寒时节，走进濮阳新型化工基地，将视线从炼油企业河南丰利石化有限公司（以下简称"丰利石 化"）的工业管廊向南延伸，便撞进信德新材料产业园全力拼抢一季度的现场。这里，是"一滴原油"价值"裂 变"的新起点。 寒风中，由银白色管道组成的巨型装置轰鸣不息，蒸汽喷薄，热气腾腾。这是信德新材料产业园一期项目自 去年9月建成后的常态。据统计，该项目试运行两个月即创下12.4亿元产值。 与一期项目一墙之隔，信德新材料产业园二期项目也在去年9月启动建设。塔吊与运输车作业忙碌，为今年6 月投产奠定基础；未来，项目将产出负极前驱体等高附加值新材料，成为产业园"投资超百亿"向"产值超百 亿"跨越的主引擎。 "从油品到化工产品可一站式转化。"信德新材料产业园总经理傅超说，产业园深度嵌入本地产业生态，与丰 利石化、华辰化工形成闭环联动，打通从原油炼制到高端化工新材料的产业链条。 原油是现代石油化工体系的基石。作为我省唯一手握原油进口权和进口原油使用权的地方炼油企业，丰利石 化在濮阳的产业版 ...

Core Viewpoint - The article highlights the rapid development and technological advancements of Duofluoride New Materials Co., Ltd. in the new energy sector, particularly in lithium-ion battery production, and the broader growth of the new materials industry in Jiaozuo City, which is becoming a key pillar of the local economy [1][2][3]. Group 1: Company Developments - Duofluoride's new energy technology company has achieved a daily production capacity of 160,000 battery cells in its fully automated production facility [1]. - The company is a leader in the fluorine materials sector, producing lithium hexafluorophosphate, which is used in one out of every three lithium batteries globally [1]. - Duofluoride's electronic-grade hydrogen fluoride production has reached world-class levels, and its high polymer products have consistently ranked first in global production and sales [2]. Group 2: Industry Growth - Jiaozuo's new materials industry has grown to include 397 enterprises, surpassing a scale of 100 billion yuan, with five major segments: new energy battery materials, modern chemical new materials, aluminum-based and titanium-zirconium alloy materials, green building materials, and superhard materials [3]. - The new materials industry in Jiaozuo has been recognized with several accolades, including the designation of its lithium-ion battery materials cluster as a strategic emerging industry cluster in Henan Province [3]. - Future plans for the new materials industry in Jiaozuo include focusing on solid-state and flow batteries, as well as developing new metal materials and advanced materials like carbon and semiconductor materials [3][4]. Group 3: Collaborative Projects - Jiaozuo has signed agreements with various companies, including a partnership with Hangzhou Jinjiang Group to collaborate on projects related to recycled aluminum and basalt fiber [4]. - Ongoing discussions with Yongjin Technology Group aim to enhance high-end titanium alloy production and industry chain collaboration, positioning Jiaozuo as a significant hub for titanium material processing [4].

Core Viewpoint - The article highlights the transformation of Wang's Group from a traditional construction and real estate company to a player in the biopharmaceutical industry, exemplified by its subsidiary, Zhiwei Pharmaceutical, which has developed innovative drugs and is advancing multiple clinical trials [1][2]. Company Overview - Zhiwei Pharmaceutical has developed a Class I innovative drug, a BTK inhibitor TM471-1, which has entered Phase II clinical trials for one indication, with several others expected to follow [1]. - The company has secured four international PCT patents covering over 30 countries and regions, showcasing its global reach and innovation capabilities [2]. Industry Development - The biopharmaceutical sector is identified as a promising and growing market, with New Xiang City being a strategic hub for this industry, housing over 140 industrial enterprises contributing significantly to the local economy [2]. - The local government has been proactive in fostering the biopharmaceutical industry through partnerships with educational institutions and the establishment of high-level platforms to support innovation [2][4]. Research and Innovation - New Xiang City is home to numerous research and development platforms, including 10 national-level and 140 provincial-level labs, which are crucial for driving advancements in the biopharmaceutical field [4]. - The city is expanding its biopharmaceutical landscape, with nearly 2,000 varieties of products, including blood products, vaccines, and antibiotics, and is leading in several medical fields [4]. Future Prospects - Companies in New Xiang are not only focusing on existing markets but are also venturing into high-end medical devices and diagnostics, indicating a shift towards more advanced healthcare solutions [3]. - The integration of academic research with industry practices is expected to enhance the innovation capacity and market competitiveness of the biopharmaceutical sector in New Xiang [4].

Core Viewpoint - The article highlights the rapid development and technological advancements of Duofluoride New Materials Co., Ltd. in the field of new energy battery production, emphasizing its significant role in the new materials industry in Jiaozuo, China [2][3][4]. Group 1: Company Overview - Duofluoride has established an automated production facility for power batteries with an annual capacity of 8GWh, achieving a daily output of 160,000 battery cells [2]. - The company is a leader in the fluorine materials sector, producing lithium hexafluorophosphate, which is used in one out of every three lithium batteries globally [3]. - Duofluoride's electronic-grade hydrofluoric acid production has reached world-class levels, and it has maintained the highest global sales for polymer products like alumina and anhydrous aluminum fluoride [3]. Group 2: Industry Development - Jiaozuo's new materials industry has grown to include 397 enterprises, surpassing a scale of 100 billion yuan, with five key segments: new energy battery materials, modern chemical new materials, aluminum-based and titanium-zirconium alloy materials, green building materials, and superhard materials [4]. - The new materials industry in Jiaozuo has been recognized for its innovation, with clusters for new energy storage devices and lithium-ion battery materials being designated as strategic emerging industry clusters in Henan Province [4]. - Future plans for Jiaozuo's new materials industry include focusing on solid-state and flow batteries, as well as developing new metal materials and advanced materials like carbon and semiconductor materials [4][5].

Group 1 - The company, Xinzuobiao, has received the "High-tech Enterprise Certificate" issued by the Zhejiang Provincial Department of Economy and Information Technology, Zhejiang Provincial Department of Finance, and the State Taxation Administration of Zhejiang Province [2] - The certificate number is GR202533006969, and it was issued on December 19, 2025, with a validity period of three years [2] - Upon receiving this certification, the company can pay corporate income tax at a rate of 15% for three consecutive years starting from the date of recognition [2]

格隆汇1月20日丨新坐标(603040.SH)公布，公司于近日收到由浙江省经济和信息化厅，浙江省财政厅， 国家税务总局浙江省税务局联合颁发的《高新技术企业证书》，证书编号GR202533006969，发证时间 2025年12月19日，证书有效期三年。本次高新技术企业的认定系公司原高新技术企业证书有效期满后的 重新认定。 ...

格隆汇1月20日丨新坐标(603040.SH)公布，公司于近日收到由浙江省经济和信息化厅，浙江省财政厅， 国家税务总局浙江省税务局联合颁发的《高新技术企业证书》，证书编号GR202533006969，发证时间 2025年12月19日，证书有效期三年。本次高新技术企业的认定系公司原高新技术企业证书有效期满后的 重新认定。 ...

证券代码：603040 证券简称：新坐标 公告编号：2026-002 杭州新坐标科技股份有限公司 关于获得高新技术企业证书的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 特此公告。 杭州新坐标科技股份有限公司董事会 2026 年 1 月 21 日 杭州新坐标科技股份有限公司（以下简称"公司"）于近日收到由浙江省经 济和信息化厅，浙江省财政厅，国家税务总局浙江省税务局联合颁发的《高新技 术企业证书》，证书编号 GR202533006969，发证时间 2025 年 12 月 19 日，证书 有效期三年。 本次高新技术企业的认定系公司原高新技术企业证书有效期满后的重新认 定，根据国家相关规定，公司自通过高新技术企业重新认定起连续三年可继续享 受国家关于高新技术企业的税收优惠政策，即按 15%的税率缴纳企业所得税。公 司 2025 年已根据相关规定按照 15%的企业所得税税率进行财务核算，因此本次 通过高新技术企业重新认定不会对公司经营业绩产生重大影响。 ...

Macro Changes - The market's rise at the beginning of 2026 is fundamentally a continuation of the global "easing consensus" from 2025, but three marginal changes are disrupting this trend [3] - The U.S. political cycle is intensifying the clash with monetary policy, as Trump pressures the Federal Reserve to lower interest rates, leading to heightened market expectations for a rate cut [3][7] - The expansion of "shadow banking" in the U.S. has shifted from a hidden concern to a significant variable, with money market funds and private credit rapidly growing, which could amplify liquidity and asset bubbles [4] Policy Dynamics - The Federal Reserve faces three constraints: persistent inflation, political pressure, and the balance between shrinking and expanding its balance sheet [7] - The European Central Bank and other global central banks are signaling potential policy shifts in response to U.S. monetary policy changes, indicating a global interconnectedness in policy decisions [8] Asset Implications - U.S. Treasury yields may steepen if rate cuts occur, but long-term rates could remain suppressed due to fiscal deficits [9] - The U.S. stock market is supported by liquidity expectations, but shadow banking could increase volatility through retail leverage [9] - Gold prices are expected to rise due to declining real interest rates and increased demand for safe-haven assets [9] Investment Shifts - China's "deposit migration" reflects a shift in asset allocation from risk-free to risk-return matching, impacting A-shares, Hong Kong stocks, and the bond market [11] - A-shares are transitioning from "stock game" to "incremental drive," with significant capital moving into equity markets, benefiting high-dividend and growth sectors [11] - Hong Kong stocks are experiencing dual elasticity, attracting both domestic and foreign investments due to improving fundamentals and lower financing costs [12] Conclusion - The global market in 2026 represents a struggle between normalized policy interventions and spontaneous market dynamics, with shadow banking and deposit migration indicating a new era for emerging market assets [13] - Investors should focus on policy-sensitive assets, growth-oriented investments, and safe-haven assets to navigate the evolving landscape [13]